Rustagi is also adjusting his air-purifying respirator, which features a different design. Buonomo is testing his powered air-purifying respirator for flow. Image credit: Andrew Brodhead Joe Buonomo, a postdoctoral research fellow in chemistry, and Arjun Rustagi, a postdoctoral medical fellow in infectious diseases, don personal protective equipment before entering the lab. Now, the lab is fully operational and researchers there are working with SARS-CoV-2.Ī typical lab bench setup in the Biosafety Level 3 lab.
In late August – before the lab was officially up and running – Joe Buonomo, a postdoctoral research fellow in chemistry, and Arjun Rustagi, a postdoctoral medical fellow in infectious diseases, showed Stanford News photographer Andrew Brodhead what work in the BS元 lab would look like. The BS元 is administered by the Innovative Medicines Accelerator, a part of Stanford’s Long-Range Vision that is designed to help faculty generate and test new medicines to slow the spread of disease. This type of lab is capable of handling airborne microbes that can cause serious or potentially lethal disease. With the aim of enhancing research on SARS-CoV-2, the virus responsible for COVID-19, Stanford University has expanded its Biosafety Level 3 (BS元) lab. Read our updates about those initiatives and their progress. Stanford’s Long-Range Vision lays out the future direction for the university’s research, education and impact.
0 kommentar(er)
